The Patent Finder

Destiny Pharma Limited

Also on record
Records under this name other than patents Destiny Pharma Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Destiny Pharma Limited

PatentTitleStatus Expires Confidence
US 8,084,602Porphyrin Derivatives and Their Use in Photodynamic Therapy
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 7,977,474Novel Uses of Porphyrin Compounds
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,326,511Methods of Inhibiting Microbial Biofilms
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,244,841Porphyrin Derivatives and Their Use in Photodynamic Therapy
Term ended
Term ended Dec 23, 2023 · High confidence
Term endedTerm ended Dec 23, 2023High confidence
US 6,630,128Porphyrin derivatives their use in photodynamic therapy and medical devices containing them
Lapsed on the fee record
Ended Oct 7, 2015 · From the USPTO record
Lapsed on the fee recordEnded Oct 7, 2015From the USPTO record
US 6,863,693Phospholipid-coated implants
Lapsed on the fee record
Ended Mar 8, 2009 · From the USPTO record
Lapsed on the fee recordEnded Mar 8, 2009From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited